Industrial Liquidators

Neuralstem, Inc. is a biopharmaceutical company based in San Diego, CA, specializing in the research and development of innovative therapies for nervous system diseases. Utilizing their neural stem cell technology, the company is focused on finding novel treatments for conditions such as major depressive disorder, Angelman syndrome, cognitive impairment, neuropathy associated with diabetes, and stroke. With a diverse pipeline of clinical programs, Neuralstem is actively developing both small molecule and stem cell therapy approaches. Their lead asset, NSI-189, is currently in clinical development for major depressive disorder and in preclinical development for various other indications. Committed to advancing their research, Neuralstem seeks partnerships and collaborations to support their programs and bring their innovative nervous system therapies to market.Generated from the website

Cidara Therapeutics, based in San Diego, CA, specializes in developing targeted immunotherapies aimed at enhancing patient outcomes for those facing serious diseases. The company's innovative Cloudbreak platform combines targeted small molecules and peptides with human antibody fragments to create drug-Fc conjugate (DFC) immunotherapies that engage the immune system and inhibit specific disease targets. With a commitment to improving the standard of care, Cidara Therapeutics focuses on transformative solutions in areas such as immuno-oncology and influenza. Their approach represents a significant advancement in the field of targeted immunotherapy, reflecting their mission to save lives through cutting-edge medical innovation. Generated from the website